MGTX

$9.321.79%-0.17

Meiragtx Holdings Plc (MGTX)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$9.49

Aprire:

$9.49

Volume 24 ore:

580,105

Volume relativo:

0.97

Capitalizzazione di mercato:

$895.12M

Reddito:

$79.76M

Utile/perdita netta:

-$120.53M

Rapporto P/E:

EPS:

-$1.49

Flusso di cassa netto:

$3.75M

1W Prestazione:

-0.85%

1M Prestazione:

-13.62%

6M Prestazione:

-0.96%

1Y Prestazione:

+6.76%

Intervallo 1D:

$0.00$0.00

Intervallo di 1 settimana:

$9.11$9.92

Portata 52W:

$6.62$15.35

Profilo aziendale di Meiragtx Holdings Plc (MGTX)

Nome

Meiragtx Holdings Plc

Settore

Healthcare

Industria

Biotechnology

Telefono

646-860-7985

Indirizzo

655 THIRD AVENUE, NEW YORK, NY, USA

Dipendente

403

@MeiraGTx

Prossima data di guadagno

2026-11-12

Ultimi documenti SEC

SEC

Discussioni di MGTX su X

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Meiragtx Holdings Plc Azioni (MGTX) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-09-24	Iniziato	Goldman	Neutral
2025-11-24	Iniziato	H.C. Wainwright	Buy
2025-10-21	Iniziato	Raymond James	Strong Buy
2024-07-31	Resumed	Chardan Capital Markets	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Outperform
2020-09-15	Resumed	BofA Securities	Buy
2019-09-03	Iniziato	Piper Jaffray	Overweight
2019-02-27	Reiterato	Chardan Capital Markets	Buy
2018-07-03	Iniziato	Barclays	Overweight
2018-07-03	Iniziato	BofA/Merrill	Buy

Meiragtx Holdings Plc Azioni (MGTX) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	81.39	33.28	14.02	15.92	37.70
Research and development USD (M)	129.62	119.48	103.79	85.73	67.13
Operating expenses USD (M)	187.36	197.49	151.08	132.28	110.89
Operating income USD (M)	-105.97	-164.21	-137.06	-116.36	-73.19
Income before tax USD (M)	-114.20	-147.79	-84.03	-129.62	-79.56
Income tax expense USD (M)	0.00	0.00	-9.66	-25.96	0.00
Net income USD (M)	-114.20	-147.79	-84.03	-129.62	-79.56
Basic EPS USD/shares	-1.42	-2.12	-1.49	-2.87	-1.80
Diluted EPS USD/shares	-1.42	-2.12	-1.49	-2.87	-1.80
Basic weighted shares shares (M)	80.43	69.82	56.49	45.18	44.14
Diluted weighted shares shares (M)	80.43	69.82	56.49	45.18	44.14

Meiragtx Holdings Plc Azioni (MGTX) insider trading

Giroux RichardOct 20 '26
CFO & COO
Transazione
Sale
Costo
$9.95
#Azioni
56,000
Valore ($)
557,200
#Azioni Totale
852,530
Richard GirouxOct 20 '26
Officer
Transazione
Proposed Sale
Costo
$9.95
#Azioni
56,000
Valore ($)
557,200
#Azioni Totale
0
Naylor StuartOct 06 '26
Officer
Transazione
Proposed Sale
Costo
$10.64
#Azioni
27,659
Valore ($)
294,321
#Azioni Totale
0
Naylor StuartOct 06 '26
CHIEF SCI OFCR, OPHTHALMOLOGY
Transazione
Sale
Costo
$10.64
#Azioni
27,659
Valore ($)
294,292
#Azioni Totale
613,187
Alexandria ForbesAug 18 '26
Officer
Transazione
Proposed Sale
Costo
$13.86
#Azioni
62,000
Valore ($)
859,320
#Azioni Totale
0
Forbes AlexandriaAug 18 '26
PRESIDENT & CEO
Transazione
Sale
Costo
$13.86
#Azioni
62,000
Valore ($)
859,320
#Azioni Totale
1,325,695
Giroux RichardJul 21 '26
CFO & COO
Transazione
Sale
Costo
$12.51
#Azioni
56,000
Valore ($)
700,560
#Azioni Totale
908,530
Richard GirouxJul 21 '26
Officer
Transazione
Proposed Sale
Costo
$12.51
#Azioni
56,000
Valore ($)
700,560
#Azioni Totale
0
Naylor StuartJul 07 '26
CHIEF SCI OFCR, OPHTHALMOLOGY
Transazione
Sale
Costo
$14.80
#Azioni
27,659
Valore ($)
409,470
#Azioni Totale
640,846
Naylor StuartJul 07 '26
Officer
Transazione
Proposed Sale
Costo
$13.33
#Azioni
27,659
Valore ($)
368,694
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Giroux Richard	CFO & COO	Oct 20 '26	Sale	$9.95	56,000	557,200	852,530
Richard Giroux	Officer	Oct 20 '26	Proposed Sale	$9.95	56,000	557,200	0
Naylor Stuart	Officer	Oct 06 '26	Proposed Sale	$10.64	27,659	294,321	0
Naylor Stuart	CHIEF SCI OFCR, OPHTHALMOLOGY	Oct 06 '26	Sale	$10.64	27,659	294,292	613,187
Alexandria Forbes	Officer	Aug 18 '26	Proposed Sale	$13.86	62,000	859,320	0
Forbes Alexandria	PRESIDENT & CEO	Aug 18 '26	Sale	$13.86	62,000	859,320	1,325,695
Giroux Richard	CFO & COO	Jul 21 '26	Sale	$12.51	56,000	700,560	908,530
Richard Giroux	Officer	Jul 21 '26	Proposed Sale	$12.51	56,000	700,560	0
Naylor Stuart	CHIEF SCI OFCR, OPHTHALMOLOGY	Jul 07 '26	Sale	$14.80	27,659	409,470	640,846
Naylor Stuart	Officer	Jul 07 '26	Proposed Sale	$13.33	27,659	368,694	0

Meiragtx Holdings Plc Borsa (MGTX) Ultime notizie

Oct 20, 2026

MeiraGTx CFO & COO Richard Giroux sells $557,200 in company shares By Investing.com - Investing.com South Africa

Oct 20, 2026

Under a trading plan, MeiraGTx (MGTX) CFO sells 56,000 shares at a $9.95 average price. - Stock Titan

Oct 20, 2026

MeiraGTx CFO Richard Giroux Executes Sale of 56,000 Shares Under Rule 10b5-1 Plan - Kalkine Media

Oct 20, 2026

A $557K share sale is proposed by MeiraGTx (MGTX) officer Richard Giroux. - Stock Titan

Oct 20, 2026

Oct 11, 2026

MeiraGTx chief scientific officer Naylor sells $294,291 in shares - Investing.com

Oct 11, 2026

Oct 06, 2026

Meiragtx chief scientific officer sells $294,291 in stock By Investing.com - Investing.com UK

Oct 06, 2026

Officer Stuart Naylor proposes selling 27,659 MeiraGTx (NASDAQ: MGTX) shares worth $294K. - Stock Titan

Oct 06, 2026

Meiragtx chief scientific officer sells $294,291 in stock - Investing.com

Oct 06, 2026

Sep 24, 2026

A 100,000-unit share award for MeiraGTx (MGTX) director Alan Sebulsky vests over three years. - Stock Titan

Sep 24, 2026

MeiraGTx (MGTX) director Alan Sebulsky reports shares held through an LLC he manages. - Stock Titan

Sep 24, 2026

Sep 13, 2026

MeiraGTx Holdings PLC Share Price - MGTX, RNS News, Articles, Quotes, & Charts - Proactive financial news

Sep 13, 2026

Sep 05, 2026

Responsive Playbooks and the MGTX Inflection - Stock Traders Daily

Sep 05, 2026

Meiragtx Holdings Stock Price Forecast. Should You Buy MGTX? - StockInvest.us

Sep 05, 2026

Sep 04, 2026

MeiraGTx Holdings (MGTX) Q2 2026 Earnings: Massive EPS Beat Driven by Non-Operating Items, Stock Still Slips - Revenue Per Share - siam.in

Sep 04, 2026

MeiraGTx Holdings (MGTX) Q2 2026 Earnings: Massive EPS Beat Driven by Non-Operating Items, Stock Still Slips - dars.gov.et

Sep 04, 2026

Sep 02, 2026

MeiraGTx (MGTX) Slips 2.89% to $13.78 as Gene-Therapy Stock Approaches Support - Jelly Roll Trade - vinanet.vn

Sep 02, 2026

Regencell Bioscience Holdings Ltd (RGC) Peer Comparison – Compare with Others - Value Research

Sep 02, 2026

Aug 26, 2026

MeiraGTx (MGTX) Results at a Glance: Reported EPS Misses Expectations under the Current Snapshot; Closing Move - careplusvn.com

Aug 26, 2026

MeiraGTx (MGTX) Results at a Glance: Reported EPS Misses Expectations under the Current Snapshot; Closing Move - dars.gov.et

Aug 26, 2026

Aug 25, 2026

Why MeiraGTx (MGTX) Is Up 7.7% After Swing to Q2 Profitability and New Leadership Hires - simplywall.st

Aug 25, 2026

Aug 24, 2026

MeiraGTx (MGTX) Earnings Reading: Profit Per Share Falls Below Its Benchmark in the Reported Period; Closing Move - vinanet.vn

Aug 24, 2026

MeiraGTx (MGTX) Earnings Reading: Profit Per Share Falls Below Its Benchmark in the Reported Period; Closing Move: The Stock Records a 1.05% Decrease in the Available Record - Earnings Call Q&A - careplusvn.com

Aug 24, 2026

MeiraGTx (MGTX) Earnings Reading: Profit Per Share Falls Below Its Benchmark in the Reported Period; Closing Move - dars.gov.et

Aug 24, 2026

MeiraGTx (MGTX) Earnings Reading: Profit Per Share Falls Below Its Benchmark in the Reported Period; Closing Move - dars.gov.et

Aug 24, 2026

MeiraGTx (MGTX) Earnings Reading: Profit Per Share Falls Below Its Benchmark in the Reported Period; Closing Move - dars.gov.et

Aug 24, 2026

Aug 21, 2026

MeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen - ChartMill

Aug 21, 2026

Tocqueville Asset Management L.P. Makes New $1.05 Million Investment in MeiraGTx Holdings PLC $MGTX - MarketBeat

Aug 21, 2026

Aug 18, 2026

MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $859,320 - Bitget

Aug 18, 2026

Meiragtx CEO Forbes sells $859,320 in company stock By Investing.com - Investing.com Australia

Aug 18, 2026

Meiragtx CEO Forbes sells $859,320 in company stock By Investing.com - Investing.com Australia

Aug 18, 2026

Alexandria Forbes Sells 62,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock - MarketBeat

Aug 18, 2026

Meiragtx CEO Forbes sells $859,320 in company stock - Investing.com

Aug 18, 2026

Meiragtx CEO Forbes sells $859,320 in company stock By Investing.com - Investing.com South Africa

Aug 18, 2026

Meiragtx CEO Forbes sells $859,320 in company stock By Investing.com - Investing.com Nigeria

Aug 18, 2026

Meiragtx CEO Forbes sells $859,320 in company stock By Investing.com - Investing.com UK

Aug 18, 2026

Meiragtx CEO Forbes sells $859,320 in company stock - Investing.com

Aug 18, 2026

MeiraGTx (MGTX) holder readies new sale after recent 62K-share cashout - Stock Titan

Aug 18, 2026

MeiraGTx (MGTX) CEO sells 62K shares in preset plan at $13.86 - stocktitan.net

Aug 18, 2026

MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot - vinanet.vn

Aug 18, 2026

MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot - careplusvn.com

Aug 18, 2026

MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot; Reported Share Move: Shares Move Higher 0.22% on the Day - Earnings Turnaround - dars.gov.et

Aug 18, 2026

MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot; Reported Share Move: Shares Move Higher 0.22% on the Day - Pretax Income Report - dars.gov.et

Aug 18, 2026

MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot - www.dars.gov.et

Aug 18, 2026

Aug 17, 2026

FY2026 EPS Estimates for MeiraGTx Increased by HC Wainwright - MarketBeat

Aug 17, 2026

Aug 16, 2026

MeiraGTx (MGTX) Jumps 6.7% to $13.52 as Gene Therapy Pipeline Optimism Grows - Weak Sell Signals - vinanet.vn

Aug 16, 2026

Johnson & Johnson Takes $89.72 Billion Position in MeiraGTx Holdings PLC $MGTX - MarketBeat

Aug 16, 2026

Price-Driven Insight from (MGTX) for Rule-Based Strategy - Stock Traders Daily

Aug 16, 2026

Aug 15, 2026

Profit Surge and New Leadership Might Change The Case For Investing In MeiraGTx Holdings (MGTX) - simplywall.st

Aug 15, 2026

Profit Surge and New Leadership Might Change The Case For Investing In MeiraGTx Holdings (MGTX) - simplywall.st

Aug 15, 2026

MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat

Aug 15, 2026

Simile a MGTX